Mounting evidence suggests that RAF-mediated MEK activation plays a crucial role in paradox MAPK (re)activation, leading to resistance and therapeutic failure with agents hitting a single step along the MAPK cascade.
Product ID:
103734
Handle IRIS:
11562/983403
Last Modified:
November 12, 2022
Bibliographic citation:
DEL CURATOLO, Anais; Conciatori, Fabiana; Cesta Incani, Ursula; Bazzichetto, Chiara; Falcone, Italia; Corbo, Vincenzo; D'Agosto, Sabrina; Eramo, Adriana; Sette, Giovanni; Sperduti, Isabella; De Luca, Teresa; Marabese, Mirko; Shirasawa, Senji; De Maria, Ruggero; Scarpa, Aldo; Broggini, Massimo; Del Bufalo, Donatella; Cognetti, Francesco; Milella, Michele; Ciuffreda, Ludovica,
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models«JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH»
, vol. 37
, n. 1
, 2018
, pp. 140-140